Peer-reviewedCC BY-NC-NDJAMA network open
Disparities in α1-Antitrypsin Deficiency Testing and Treatment in US Adults
- 1Pulmonary, Allergy, Critical Care, and Sleep Medicine, Minneapolis VA Health Care System, Minneapolis, Minnesota
- 2Research Department, Minneapolis VA Health Care System, Minneapolis, Minnesota
- 3Pulmonary and Critical Care Medicine, Integrated Hospital Care Institute, Cleveland Clinic, Cleveland, Ohio
Related
- Disparities in α ₁ -Antitrypsin Deficiency Testing and Treatment in US Adults
- Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency‐associated lung disease
- Validation of the Bronchiectasis Severity Index in alpha-1 antitrypsin deficiency
- Treatment of growth hormone deficiency with long-acting growth hormones in children, adolescents and adults: Clinical evidence and practical considerations
- Socioeconomic disparities in access to care and healthcare expenditures among U.S. adults: evidence from the Medical Expenditure Panel Survey, 2018–2022
BibTeX
@article{baldomero2026disparities,
title = {{Disparities in α1-Antitrypsin Deficiency Testing and Treatment in US Adults}},
author = {Arianne K. Baldomero and Lisa Smith and Amy Gravely and Vickram Tejwani and Chris H. Wendt},
journal = {JAMA network open},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13673321},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Disparities in α1-Antitrypsin Deficiency Testing and Treatment in US Adults
AU - Arianne K. Baldomero
AU - Lisa Smith
AU - Amy Gravely
AU - Vickram Tejwani
AU - Chris H. Wendt
PY - 2026
DA - 2026/10/01
JO - JAMA network open
UR - https://europepmc.org/article/PMC/PMC13673321
SN - 2574-3805
ER -